The global nuclear pharmacy market is expected to show a robust growth with an impressive CAGR in the forecast years 2022-2026, on the account of increasing demands of the nuclear medicines. Specialized pharmacy unit demands for the nuclear pharmaceutical products is driving the growth of the global nuclear pharmacy market in the upcoming five years. Radiopharmacology is also one of the major factors supporting the growth of the global nuclear pharmacy market in the next five years.

Nuclear pharmacy is the specialized pharmacy that are storage houses and distribution channel for nuclear medicines. They are also known as the radio pharmacy that involves preparation of radioactive material for the administration to the patients diagnosed with specific diseases like cancer. The increasing instances of cancer and carcinogenic agents causing severe diseases require radioactive drugs to diagnose and treat the specific diseases. The process of nuclear treatment involves a combination of radionuclide tracer with the pharmaceutical product such that easier diagnosis of the diseased location can be tracked biologically.

Increasing Instances of Cancer Drives Market Growth

Surging instances of cancer is anticipated to drive the growth of the global nuclear pharmacy market in the upcoming five years. Countries like Australia, New Zealand, Ireland is some of the top-most countries that register largest population of cancer suffering patients. About 70% of the deaths in the recent times before pandemic was registered due to cancer.

Using tobacco for smoking, chewing, and excessive drinking are some of the major reasons that increase the chances of a human suffering from cancer. The cases are also often genetically transmitted or mutated in the genetic material of a human being. Infections like, hepatitis and human papillomavirus (HPV) are also responsible for causing cancer.

Since the diagnosis of the disease is very difficult, the disease often reaches extreme levels before getting diagnosed and treatment becomes difficult and, in some cases, even fatal. Late stage presentation and lack of access to the effective treatment in the developing and economically weak countries, is increasing the instances of cancer, and thus supporting the growth of the global nuclear pharmacy market in the future five years.

Advancing Nuclear Medicine Supports Market Growth

Consistent research and technological advancements are supporting the future growth of the global nuclear pharmacy market in future five years. Appropriate storage units, maintained conditions for cold storage and radioactive drugs, is a necessity for nuclear pharmacy set-up. Moreover, advancements and designer nuclear medicines is further aiding the growth of the global nuclear pharmacy market in the upcoming five years.

Studies are also being carried to enhance radiotherapy. Various cardiovascular diseases, thyroid diseases, respiratory diseases, bone diseases, and neurological diseases are treated via nuclear therapies, thus substantiating the growth of the global nuclear pharmacy market in the upcoming five years. Some of the examples of nuclear medicine are as follows:

  • Hafnium oxide nanoparticle NBTXR3 as a radio enhancer to improve the response of radiotherapy for soft-tissue sarcoma.
  • Rhenium-188 is one of the rarest radioactive particles that is used in cancer therapies to cure squamous cell carcinoma or basal cell carcinoma that are major skin cancer conditions.
  • Samarium-153, and Strontium-89 are radioactive isotopes that are used for palliative and chronic bone pain treatments.
  • Radioisotope of iodine, as Iodine-131-sodium iodide is utilized for the hyperthyroidism and thyroid cancer conditions in humans. The radioactive isotopes sometimes cause severe side effects.

Rising Investment in Healthcare Industry

Government around the world are actively investing their resources and providing financial support to the pharmaceutical companies to set up specialized nuclear pharmacies. The availability of the nuclear pharmacies near the cancer therapy centers is increasing. The demand for such nuclear pharmacies in the more remote locations and easily approachable for the larger population of the world is supporting the growth of the global nuclear pharmacy market in the upcoming five years.


Click here to download the sample

Market Segmentation

The global nuclear pharmacy market is segmented on the basis of type, purpose, competitional landscape, and regional distribution. Based on type, the market is further fragmented into institutional, and commercial. On the basis of purpose, the market is bifurcated into diagnostic, and therapeutic. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profiles

Jubilant Radiopharma (Jubilant Pharma Holdings Inc.), GE Healthcare, Cardinal Health, Inc., ARTMS Inc., AnazaoHealth Corp., SOFIE, Pacific Radiopharmacy, Ltd., are among the major market players in the global platform that lead the market growth of the global nuclear pharmacy market.

Attribute

Details

Base Year

2020

Historical Data

2016 – 2019

Estimated Year

2021

Forecast Period

2022 – 2026

Quantitative Units

Revenue in USD Million, and CAGR for 2016-2020 and 2021-2026

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Type
  • Purpose

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Malaysia, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia

Key companies profiled

Jubilant Radiopharma (Jubilant Pharma Holdings Inc.), GE Healthcare, Cardinal Health, Inc., ARTMS Inc., AnazaoHealth Corp., SOFIE, Pacific Radiopharmacy, Ltd.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global nuclear pharmacy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Nuclear Pharmacy Market, By Type:
    • Institutional
    • Commercial
  • Nuclear Pharmacy Market, By Purpose:
    • Diagnostic
    • Therapeutic
  • Nuclear Pharmacy Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nuclear pharmacy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Nuclear Pharmacy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Nuclear Pharmacy Market

4.    Voice of Customer

4.1.  Brand Awareness

4.2.  Commonly Prepared Radiopharmaceuticals at Nuclear Pharmacies

4.3.  Barriers to Adoption of Nuclear Pharmacy

5.    Executive Summary

6.    Global Nuclear Pharmacy Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Institutional v/s Commercial)

6.2.2.     By Purpose (Diagnostic v/s Therapeutic)

6.2.3.     By Company (2020)

6.2.4.     By Region

6.3.  Product Market Map

7.    North America Nuclear Pharmacy Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Purpose

7.2.3.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Nuclear Pharmacy Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Purpose

7.3.2.     Mexico Nuclear Pharmacy Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Purpose

7.3.3.     Canada Nuclear Pharmacy Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Purpose

8.    Europe Nuclear Pharmacy Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Purpose

8.2.3.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Nuclear Pharmacy Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Purpose

8.3.2.     Germany Nuclear Pharmacy Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Purpose

8.3.3.     United Kingdom Nuclear Pharmacy Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Purpose

8.3.4.     Italy Nuclear Pharmacy Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Purpose

8.3.5.     Spain Nuclear Pharmacy Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Purpose

9.    Asia-Pacific Nuclear Pharmacy Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Purpose

9.2.3.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Nuclear Pharmacy Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Purpose

9.3.2.     India Nuclear Pharmacy Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Purpose

9.3.3.     South Korea Nuclear Pharmacy Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Purpose

9.3.4.     Japan Nuclear Pharmacy Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Purpose

9.3.5.     Australia Nuclear Pharmacy Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Purpose

10.  South America Nuclear Pharmacy Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Purpose

10.2.3.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Nuclear Pharmacy Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Purpose

10.3.2.  Argentina Nuclear Pharmacy Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Purpose

10.3.3.  Colombia Nuclear Pharmacy Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Purpose

11.  Middle East and Africa Nuclear Pharmacy Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Purpose

11.2.3.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Nuclear Pharmacy Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Purpose

11.3.2.  Saudi Arabia Nuclear Pharmacy Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Purpose

11.3.3.  UAE Nuclear Pharmacy Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Purpose

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)

14.2.              GE Healthcare

14.3.              Cardinal Health, Inc.

14.4.              ARTMS Inc.

14.5.              AnazaoHealth Corp.

14.6.              SOFIE

14.7.              Pacific Radiopharmacy, Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com